- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-5076
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Homologous recombination deficiency in breast cancer ; day:9 ; month:6 ; year:2020 ; pages:1-5
Magazine of European Medical Oncology ; (9.6.2020), 1-5
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12254-020-00624-x
- URN
-
urn:nbn:de:101:1-2020080901244879010274
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bartl, Thomas
- Farr, Alex
- SpringerLink (Online service)
Other Objects (12)
Multi-scale characterisation of homologous recombination deficiency in breast cancer
Homologous recombination deficiency in epithelial ovarian cancer
Pan-cancer landscape of homologous recombination deficiency
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes
Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Leveraging homologous recombination repair deficiency in sarcoma
Targeting homologous recombination deficiency in uterine leiomyosarcoma
Homologous recombination proficiency in ovarian and breast cancer patients
Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells
Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Multi-scale characterisation of homologous recombination deficiency in breast cancer
Homologous recombination deficiency in epithelial ovarian cancer
Pan-cancer landscape of homologous recombination deficiency
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes
Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Leveraging homologous recombination repair deficiency in sarcoma
Targeting homologous recombination deficiency in uterine leiomyosarcoma
Homologous recombination proficiency in ovarian and breast cancer patients
Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells
Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Multi-scale characterisation of homologous recombination deficiency in breast cancer
Homologous recombination deficiency in epithelial ovarian cancer
Pan-cancer landscape of homologous recombination deficiency
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes
Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Leveraging homologous recombination repair deficiency in sarcoma
Targeting homologous recombination deficiency in uterine leiomyosarcoma
Homologous recombination proficiency in ovarian and breast cancer patients
Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells